BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ProStrakan Group 



Galashiels      Scotland
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
ProStrakan Group Launching SANCUSO (Granisetron Transdermal System) in European Union With 3M Drug Delivery Systems as Manufacturer 9/30/2013 10:54:01 AM    More...
ProStrakan Group Acquires Breast Cancer Product for $21.7 Million 10/1/2012 7:14:44 AM    More...
Orexo AB Acquires All US Rights for ProStrakan Group's Abstral and Receives a Net Cash Consideration of £55 Million 6/4/2012 7:52:09 AM    More...
FDA Approves ProStrakan Group's Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 1/3/2012 7:07:08 AM    More...
ProStrakan Group Receives FDA Approval for Rectiv(TM) for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures 6/22/2011 7:43:13 AM    More...
ProStrakan Group's ABSTRAL(R) (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S. 4/4/2011 7:05:34 AM    More...
Testosterone Gel from ProStrakan Group Shows Effects on Diabetes 3/25/2011 7:29:48 AM    More...
Japanese Company Kyowa Hakko Kirin to Buy ProStrakan Group for £292 Million 2/22/2011 8:14:12 AM    More...
ProStrakan Group Chooses RelayHealth for Approved Abstral REMS Program 1/20/2011 8:12:30 AM    More...
Paladin Labs Inc. (CC:PLB): Completion of Financing Agreement With ProStrakan Group 1/13/2011 9:43:55 AM    More...
12345678

//-->